Jump to ContentJump to Main Navigation
Show Summary Details
In This Section

Journal of Perinatal Medicine

Official Journal of the World Association of Perinatal Medicine

Editor-in-Chief: Dudenhausen, Joachim W.

Editorial Board Member: / Bancalari, Eduardo / Milner, Anne / Genc, Mehmet R. / Chervenak, Frank A. / Chappelle, Joseph / Bergmann, Renate L. / Bernardes, J.F. / Bevilacqua, G. / Blickstein, Isaac / Cabero Roura, Luis / Carbonell-Estrany, Xavier / Carrera, Jose M. / D`Addario, Vincenzo / D'Alton, MD, Mary E. / Dimitrou, G. / Grunebaum, Amos / Hentschel, Roland / Köpcke, W. / Kawabata, Ichiro / Keirse, Marc J.N.C. / Kurjak M.D., Asim / Lee, Ben H. / Levene, Malcolm / Lockwood, Charles J. / Marsal, Karel / Makatsariya, Alexander / Nishida, Hiroshi / Papp, Zoltán / Pejaver, Ranjan Kumar / Pooh, Ritsuko K. / Romero, Roberto / Saugstad, Ola D. / Schenker, Joseph G. / Sen, Cihat / Seri, Istvan / Vetter, Klaus / Winn, Hung N. / Young, Bruce K. / Zimmermann, Roland

9 Issues per year


IMPACT FACTOR 2016: 1.577
5-year IMPACT FACTOR: 1.705

CiteScore 2016: 1.49

SCImago Journal Rank (SJR) 2015: 0.829
Source Normalized Impact per Paper (SNIP) 2015: 0.808

Online
ISSN
1619-3997
See all formats and pricing
In This Section
Volume 41, Issue 5 (Sep 2013)

Issues

First trimester maternal serum placental protein 13 levels in singleton vs. twin pregnancies with and without severe pre-eclampsia

Ran Svirsky
  • Ultrasound Institute, Department of Obstetrics and Gynecology, Assaf Harofeh Medical Center, Zerifin and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
/ Hamutal Meiri
  • Hy-Laboratories Ltd, Rehovot Science Park, Rehovot, Israel
  • TeleMarpe Ltd, Tel Aviv, Israel
/ Ayelet Herzog
  • Hy-Laboratories Ltd, Rehovot Science Park, Rehovot, Israel
/ Vered Kivity
  • TeleMarpe Ltd, Tel Aviv, Israel
/ Howard Cuckle
  • Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, NY, USA
/ Ron Maymon
  • Corresponding author
  • Department of Obstetrics and Gynecology, Assaf Harofeh Medical Center, Zerifin, 70300, Israel
  • Email:
Published Online: 2013-05-16 | DOI: https://doi.org/10.1515/jpm-2013-0011

Abstract

Aims: To determine first trimester maternal serum placental protein 13 (PP13) in singletons vs. twins with and without severe preeclampsia (PE).

Methods: Serum samples were prospectively collected at 8–14 weeks of gestation. PP13 was determined by solid-phase immunoassay. Patients were recruited in community clinics throughout the country, and from the twin antenatal assessment clinic in Assaf Harofeh Medical Center, Zerifin, Israel. Demographics, medical, and pregnancy history were obtained at enrollment. Pregnancy outcome was collected after delivery. PP13 was compared by the Wilcoxon rank sum test.

Results: In singletons, PP13 declined with maternal weight and was lower in in vitro fertilization. Levels were converted into multiples of the median (MoMs) accordingly. In twins, the median was 1.74 MoM (n=76) vs. 1.00 in singletons (n=676, P<0.0001). Among twins with severe PE (n=10), the median was 1.53 MoM vs. 1.74 in unaffected twins (P=0.10), and 2.26 (n=6) for mild PE (P=0.30). Among singletons with severe PE, the median was 0.44 MoM (n=26, P<0.0001), and for mild PE 0.62 (n=17, P<0.001).

Conclusion: PP13 is higher in twins than singletons, corresponding to the larger placental mass. Among singletons with severe PE, levels were significantly reduced, however, among twins, only a non-significant tendency for a reduction was recorded, and warrants further investigation in a larger series.

Keywords: Placental protein 13; prediction; pre-eclampsia; serum biomarkers; twins

References

  • [1]

    ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 2002;77:67–75.

  • [2]

    Akolekar R, Syngelaki A, Beta J, Kocylowski R, Nicolaides KH. Maternal serum placental protein 13 at 11–13 weeks of gestation in preeclampsia. Prenat Diagn. 2009;29:1103–8. [Web of Science]

  • [3]

    Balogh A, Pozsgay J, Matkó J, Dong Z, Kim CJ, Várkonyi T, et al. Placental protein 13 (PP13/Galectin-13) undergoes lipid raft-associated subcellular redistribution in the syncytiotrophoblast in preterm preeclampsia and HELLP syndrome. Am J Obstet Gynecol. 2011;205:e1–14. [Web of Science]

  • [4]

    Bdolah Y, Lam C, Rajakumar A, Shivalingappa V, Mutter W, Sachs BP, et al. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia? Am J Obstet Gynecol. 2008;198:428.e1–6.

  • [5]

    Bujold E, Roberge S, Lacass Y, Bureau M, Audibert F, Marcoux S, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol. 2010;116:402–14.

  • [6]

    Calhoun KC, Barnhart KT, Elovitz MA, Srinivas SK. Evaluating the association between assisted conception and the severity of preeclampsia. ISRN Obstet Gynecol. 2011;2011:928592. [PubMed]

  • [7]

    Caspi E, Raziel A, Sherman D, Arieli S, Bukovski I, Weinraub Z. Prevention of pregnancy-induced hypertension in twins by early administration of low-dose aspirin: a preliminary report. Am J Reprod Immunol. 1994;31:19–24. [PubMed] [Crossref]

  • [8]

    Cetin I, Huppertz B, Burton G, Cuckle H, Gonen R, Lapaire O, et al. Pregenesys pre-eclampsia markers consensus meeting: What do we require from markers, risk assessment and model systems to tailor preventive strategies? Placenta. 2011;32(Suppl 1):S4–16. [Web of Science]

  • [9]

    Chafetz I, Kuhnreich I, Sammar M, Tal Y, Gibor Y, Meiri H, et al. First-trimester placental protein 13 screening for pre-eclampsia and intrauterine growth restriction. Am J Obstet Gynecol. 2007;197:35.e1–7.

  • [10]

    Cuckle H. Screening for preeclampsia–lessons from aneuploidy screening. Placenta. 2011;32(Suppl 1):S42–8. [Web of Science]

  • [11]

    Dumoulin JC, Land JA, Van Montfoort AP, Nelissen EC, Coonen E, Derhaag JG, et al. Effect of in vitro culture of human embryos on birthweight of newborns. Hum Reprod. 2010; 25:605–12. [PubMed] [Crossref]

  • [12]

    Gielen M, Lindsey PJ, Derom C, Loos RJ, Derom R, Nijhuis JG, et al. Curves of placental weights of live- born twins. Twin Res Hum Genet. 2006;9:664–72. [PubMed] [Crossref]

  • [13]

    Giguère Y, Charland M, Bujold E, Bernard N, Grenier S, Rousseau F, et al. Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review. Clin Chem. 2010;56:361–5. [PubMed] [Web of Science] [Crossref]

  • [14]

    Gonen R, Shahar R, Grimpel YI, Chefetz I, Sammar M, Meiri H, et al. Placental protein 13 as an early marker for preeclampsia: a prospective longitudinal study. Br J Obstet Gynaecol. 2008:115;1465–72.

  • [15]

    Grimpel YI, Kivity V, Cohen A, Meiri H, Sammar M, Gonen R, et al. Effects of calcium, magnesium, low-dose aspirin and low-molecular-weight heparin on the release of PP13 from placental explants. Placenta. 2011;32(Suppl 1):S55–64.

  • [16]

    Hadlock FP, Shah YP, Kanon DJ, Lindsey JV. Fetal crown-rump length: reevaluation of relation to menstrual age (5–18 weeks) with high-resolution real-time US. Radiology. 1992;182:501–5.

  • [17]

    Huppertz B, Sammar M, Chefetz I, Neumaier-Wagner P, Bartz C, Meiri H. Longitudinal determination of serum placental protein 13 during development of pre-eclampsia. Fetal Diagn Ther. 2008;24:230–6. [Web of Science]

  • [18]

    Khalil A, Cowans NJ, Spencer K, Goichman S, Meiri H, Harrington K. First-trimester markers for the prediction of preeclampsia in women with a-priori high risk. Ultrasound Obstet Gynecol. 2010;35:671–9. [PubMed]

  • [19]

    Klein K, Mailath-Pokorny M, Elhenicky M, Schmid M, Zeisler H, Worda C. Mean, lowest, and highest pulsatility index of the uterine artery and adverse pregnancy outcome in twin pregnancies. Am J Obstet Gynecol. 2011;205:549.e1–7.

  • [20]

    Koster MP, Wortelboer EJ, Stoutenbeek P, Visser GH, Schielen PC. Distributions of current and new first-trimester Down syndrome screening markers in twin pregnancies. Prenat Diagn. 2010;30:413–7. [PubMed]

  • [21]

    Lindheimer MD, Taler SJ, Cunningham FG, American Society of Hypertension. ASH position paper: hypertension in pregnancy. J Clin Hypertens (Greenwich). 2009;11:214–25. [Crossref]

  • [22]

    Muller F, Dreux S, Dupoizat H, Uzan S, Dubin MF, Oury JF, et al. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity. Prenat Diagn. 2003;23:331–5. [Crossref] [PubMed]

  • [23]

    Noble PL, Snijders RJ, Abraha HD, Sherwood RA, Nicolaides KH. Maternal serum free beta-hCG at 10 to 14 weeks of gestation in trisomic twin pregnancies. Br J Obstet Gynaecol. 1997;104:741–3.

  • [24]

    Orendi K, Gauster M, Moser G, Meiri H, Huppertz B. Effects of vitamins C and E, acetylsalicylic acid and heparin on fusion, beta-hCG and PP13 expression in BeWo cells. Placenta. 2010;31:431–8. [Web of Science]

  • [25]

    Publications Committee, Society for Maternal-Fetal Medicine, Sibai BM. Evaluation and management of severe preeclampsia before 34 weeks’ gestation. Am J Obstet Gynecol. 2011;205:191–8.

  • [26]

    Romero R, Kusanovic JP, Than NG, Erez O, Gotsch F, Espinoza J, et al. First-trimester maternal serum PP13 in the risk assessment for preeclampsia. Am J Obstet Gynecol. 2008;199:122:e1–11.

  • [27]

    Santolaya-Forgas J, De Leon JA, Cullen Hopkins R, Castracane VD, Kauffman RP, Sifuentes GA. Low pregnancy-associated plasma protein-a at 10(+1) to 14(+6) weeks of gestation and a possible mechanism leading to miscarriage. Fetal Diagn Ther. 2004;19:456–61.

  • [28]

    Sibai BM, Caritis SN, Thom E, Klebanoff M, McNellis D, Rocco L, et al. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. New Engl J Med. 1993;329:1213–8.

  • [29]

    Sibai BM, Hauth J, Caritis S, Lindheimer MD, MacPherson C, Klebanoff M, et al. Hypertensive disorders in twin versus singleton gestations. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol. 2000;182:938–42.

  • [30]

    Spencer K. Screening for trisomy 21 in twin pregnancies in the first trimester using free beta-hCG and PAPP-A, combined with fetal nuchal translucency thickness. Prenat Diagn. 2000;20:91–5. [PubMed] [Crossref]

  • [31]

    Than NG, Romero R, Goodman M, Weckle A, Xing J, Dong Z, et al. A primate subfamily of galectins expressed at the maternal-fetal interface that promote immune cell death. Proc Natl Acad Sci USA. 2009;106:9731–6. [Web of Science]

  • [32]

    World Health Organization. Make every mother and child count. World Health Report, 2005. Geneva: World Health Organization; 2005.

About the article

Corresponding author: Prof. Ron Maymon, MD, Department of Obstetrics and Gynecology, Assaf Harofeh Medical Center, Zerifin, 70300, Israel, Tel.: +972-3-5245892, Fax: +972-3-5246867


Received: 2013-01-18

Accepted: 2013-04-12

Published Online: 2013-05-16

Published in Print: 2013-09-01



Citation Information: Journal of Perinatal Medicine, ISSN (Online) 1619-3997, ISSN (Print) 0300-5577, DOI: https://doi.org/10.1515/jpm-2013-0011. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Nandor Gabor Than, Roberto Romero, Andrea Balogh, Eva Karpati, Salvatore Andrea Mastrolia, Orna Staretz-Chacham, Sinuhe Hahn, Offer Erez, Zoltan Papp, and Chong Jai Kim
Journal of Pathology and Translational Medcine, 2015, Volume 49, Number 3, Page 181
[2]
Nándor Gábor Than, Andrea Balogh, Roberto Romero, Éva Kárpáti, Offer Erez, András Szilágyi, Ilona Kovalszky, Marei Sammar, Sveinbjorn Gizurarson, János Matkó, Péter Závodszky, Zoltán Papp, and Hamutal Meiri
Frontiers in Immunology, 2014, Volume 5
[3]
Ido Ben-Ami, Ron Maymon, Ran Svirsky, Howard Cuckle, and Eric Jauniaux
Obstetrical & Gynecological Survey, 2013, Volume 68, Number 11, Page 764
[4]
Stamatios Petousis, Chrysoula Margioula-Siarkou, Ioannis Kalogiannidis, and Nikolaos Prapas
Current Obstetrics and Gynecology Reports, 2013, Volume 2, Number 4, Page 249

Comments (0)

Please log in or register to comment.
Log in